Content about Drugs

October 25, 2013

In recognition of National Prescription Drug Take Back Day being held Oct. 26, CVS/pharmacy has launched the CVS/pharmacy Medication Disposal for Safer Communities Program.

WOONSOCKET, R.I. — In recognition of National Prescription Drug Take Back Day being held Oct. 26, CVS/pharmacy has launched the CVS/pharmacy Medication Disposal for Safer Communities Program.

The new program is designed to provide police departments across the country with an easy way to team up with CVS/pharmacy locations in their area to hold National Drug Take Back Day events or to help raise community awareness of local drug disposal programs managed by law enforcement.

October 25, 2013

The Food and Drug Administration plans to recommend stronger regulations for a commonly used opioid painkiller.

SILVER SPRING, Md. — The Food and Drug Administration plans to recommend stronger regulations for a commonly used opioid painkiller.

October 22, 2013

A top executive of generic drug maker Hospira spoke in favor of giving biosimilar drugs the same generic names as the branded biologics they're based on.

LAKE FOREST, Ill. — A top executive of generic drug maker Hospira spoke in favor of giving biosimilar drugs the same generic names as the branded biologics they're based on.

October 17, 2013

As knock-off versions of biotech drugs get closer to reality in the United States, one issue that has emerged has centered on what to call them.

NEW YORK — As knock-off versions of biotech drugs get closer to reality in the United States, one issue that has emerged has centered on what to call them.

October 16, 2013

Medicare beneficiaries' use of medications — both effective and risky — varies widely across different regions of the United States, according to a new report.

LEBANON, N.H. — Medicare beneficiaries' use of medications — both effective and risky — varies widely across different regions of the United States, according to a new report.

October 14, 2013

The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

NEW YORK — The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

October 10, 2013

When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.

When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.

Last month, the company — which specializes in making generic injectable drugs — announced that European Union regulators had approved the continent’s first biosimilar monoclonal antibody.

October 7, 2013

A trade group of generic drug makers is hoping that California's governor vetoes a bill that it says would restrict patients' access to biosimilars.

NEW YORK — A trade group of generic drug makers is hoping that California's governor vetoes a bill that it says would restrict patients' access to biosimilars.

October 1, 2013

The message in October is "Know Your Pharmacist, Know Your Medicine" as the American Pharmacists Association launches its annual American Pharmacists Month.

WASHINGTON — The message in October is "Know Your Pharmacist, Know Your Medicine" as the American Pharmacists Association launches its annual American Pharmacists Month.

September 10, 2013

The country's embryonic biosimilars industry scored a victory last month as the organization that runs the pension fund for California state employees announced its opposition to a state Senate bill provision that would impose special requirements on pharmacists who dispense follow-on biologics.

The country's embryonic biosimilars industry scored a victory last month as the organization that runs the pension fund for California state employees announced its opposition to a state Senate bill provision that would impose special requirements on pharmacists who dispense follow-on biologics.

September 10, 2013

European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.

LEAMINGTON SPA, United Kingdom — European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.

Hospira announced Tuesday the European Medicines Agency's approval of Inflectra (infliximab) for the treatment of autoimmune disorders like rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriatic arthritis and psoriasis.

September 4, 2013

A patient-engagement and Medicare decision-making platform is now available in 500 pharmacies across the country.

NEW YORK — A patient-engagement and Medicare decision-making platform is now available in 500 pharmacies across the country.

iMedicare said the growth of the platform would help thousands of seniors enroll in affordable health insurance and prescription drug coverage by enabling pharmacists to help them shop for Medicare insurance plans, automatically integrating their prescription medications in one mobile system.

iMedicare works with major pharmacy software systems like Rx30, QS/1, Computer-Rx and others.

August 29, 2013

The Food and Drug Administration is concerned about bills in several state legislatures that seek to restrict pharmacists' ability to dispense biosimilars, according to published reports.

NEW YORK — The Food and Drug Administration is concerned about bills in several state legislatures that seek to restrict pharmacists' ability to dispense biosimilars, according to published reports.

Biopharma-Reporter.com quoted an FDA spokeswoman as saying "efforts to undermine trust in these products" were cause for worry and did not serve the interests of patients.

August 27, 2013

Lawmakers in California have passed a bill that would restrict the use of follow-on versions of biotech drugs known as biosimilars, according to published reports.

NEW YORK — Lawmakers in California have passed a bill that would restrict the use of follow-on versions of biotech drugs known as biosimilars, according to published reports.

August 26, 2013

To help battle the national prescription drug abuse epidemic in the country, CVS Caremark embarked on a program whereby it tapped its extensive database to identify and halt inappropriate prescribing of high-risk drugs.

The reality is that drug stores have been caught in the middle of the nation's prescription drug abuse epidemic, and CVS Caremark’s efforts are an example of the larger role that retail pharmacy can play.

To help battle the national prescription drug abuse epidemic in the country, CVS Caremark embarked on a program whereby it tapped its extensive database to identify and halt inappropriate prescribing of high-risk drugs.

The reality is that drug stores have been caught in the middle of the nation's prescription drug abuse epidemic, and CVS Caremark’s efforts are an example of the larger role that retail pharmacy can play.

August 22, 2013

A bill under consideration by California's state legislature contains provisions that would place restrictions on pharmacists' ability to dispense knock-off versions of biotech drugs, drawing opposition from the generic pharmaceutical lobby and the state's pension fund for government employees.

SACRAMENTO, Calif. — A bill under consideration by California's state legislature contains provisions that would place restrictions on pharmacists' ability to dispense knock-off versions of biotech drugs, drawing opposition from the generic pharmaceutical lobby and the state's pension fund for government employees.

August 22, 2013

CVS Caremark is continuing its efforts to battle the national prescription drug abuse epidemic by tapping its database to identify and stop inappropriate prescribing of high-risk drugs and is working at the federal and state levels to implement policy changes to curb prescription drug abuse.

WOONSOCKET, R.I. — CVS Caremark is continuing its efforts to battle the national prescription drug abuse epidemic by tapping its database to identify and stop inappropriate prescribing of high-risk drugs and is working at the federal and state levels to implement policy changes to curb prescription drug abuse.

August 20, 2013

Generic drug maker Sandoz has relaunched a website to promote its biosimilars business.

NEW YORK — Generic drug maker Sandoz has relaunched a website to promote its biosimilars business.

August 8, 2013

CVS/pharmacy announced on Thursday the launch of a new online Drug Information Center on CVS.com, which was developed to help consumers take control of their health by providing them with drug information and a variety of innovative resources.

WOONSOCKET, R.I. — CVS/pharmacy announced on Thursday the launch of a new online Drug Information Center on CVS.com, which was developed to help consumers take control of their health by providing them with drug information and a variety of innovative resources.

August 8, 2013

The world is turning generic. That's the takeaway from the latest trends in the drug industry, according to IMS Health.

The world is turning generic. That's the takeaway from the latest trends in the drug industry, according to IMS Health. In 2012, according to the healthcare industry analytics firm, dollar sales of drugs fell by 1% to $325.7 billion, but prescriptions grew by 1.2% as generic drugs' share of total drugs dispensed grew to nearly 83%.

July 29, 2013

The Consumer Healthcare Products Association endorsed the Restoring Access to Medication Act (H.R. 2835), which would repeal a requirement enacted into law as part of the Patient Protection and Affordable Care Act of 2010 that requires consumers to obtain a prescription in order to utilize their flexible spending arrangements and health savings accounts to purchase over-the-counter medicines.

WASHINGTON — The Consumer Healthcare Products Association on Friday endorsed the Restoring Access to Medication Act (H.R. 2835) introduced by Reps. Lynn Jenkins, R-Kan., and John Barrow, D-Ga., which would repeal a requirement enacted into law as part of the Patient Protection and Affordable Care Act of 2010 that requires consumers to obtain a prescription in order to utilize their flexible spending arrangements and health savings accounts to purchase over-the-counter medicines.

July 24, 2013

The Food and Drug Administration has granted the manufacturer of Plan B One-Step exclusive marketing rights for three years, according to published reports.

WASHINGTON — The Food and Drug Administration has granted the manufacturer of Plan B One-Step exclusive marketing rights for three years, according to published reports.

According to the New York Times, the decision by the FDA sets Teva Pharmaceuticals as the only company able to sell the drug over-the-counter and without a prescription to a person of any age.

July 23, 2013

An op-ed in Tuesday’s Capitol Hill newspaper Roll Call emphasizes the National Association of Chain Drug Stores’ commitment to curbing prescription drug abuse and diversion while ensuring legitimate patient access to prescription medications.

ARLINGTON, Va. — An op-ed in Tuesday’s Capitol Hill newspaper Roll Call emphasizes the National Association of Chain Drug Stores’ commitment to curbing prescription drug abuse and diversion while ensuring legitimate patient access to prescription medications.  

July 18, 2013

According to the Administration on Aging, the United States is similar to many other countries in the developed world — and even a few in the developing world — in that the population is getting older.

According to the Administration on Aging, the United States is similar to many other countries in the developed world — and even a few in the developing world — in that the population is getting older. According to the AOA, people in the United States ages 65 years and older numbered 39.6 million in 2009, a number expected to reach 72.1 million by 2030. In 2000, the elderly represented 12.4% of the population in the United States, but will constitute 19% of it in 17 years.

July 12, 2013

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.